BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
3.75
-0.02 (-0.53%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.53%
After-hours: Aug 15, 2025, 07:16 PM EDT

BioLineRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
22.34M 28.94M 21.99M 17.05M 11.65M 4.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
7.84M 9.26M 6.87M 6.04M 5.15M 3.69M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
14.5M 19.68M 15.13M 11M 6.51M 1.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-17.98M -20.41M -34.55M -41.52M -45.66M -49.69M -39.53M -34.25M -31.93M -29.16M -27.36M -26.5M -25.41M -24.78M -24.05M -22.48M -21.54M
Interest Income
1.55M 1.82M 2.25M 2.13M 2.04M 2.01M 1.73M 1.52M 1.16M 694K 516K 459K 509K 559K 321K 308K 213K
Pretax Income
-3.4M -9.22M -19.92M -30.12M -49.15M -60.62M -52.46M -43.28M -32.18M -24.95M -23.52M -22.39M -21.79M -27.05M -34.74M -33.64M -33.57M
Net Income
-3.4M -9.22M -19.92M -30.12M -49.15M -60.61M -52.46M -43.28M -32.18M -24.95M -23.52M -22.39M -21.79M -27.05M -34.74M -33.64M -33.57M
Selling & General & Admin
21.8M 28.54M 32.58M 35.27M 34.14M 31.58M 26.64M 19.72M 15.02M 11.49M 7.99M 6.58M 5.74M 5.27M 5.01M 4.88M 4.44M
Research & Development
8.28M 9.15M 10.39M 10.55M 11.33M 12.52M 12.85M 14.49M 16.88M 17.63M 19.32M 19.88M 19.62M 19.47M 18.97M 17.53M 17.03M
Other Expenses
2.4M 2.4M 1K 1K 1K 1K 39K 39K 39K 39K 42K 42K 42K 42K 70K 70K 70K
Operating Expenses
32.48M 40.09M 42.97M 45.82M 45.47M 44.1M 39.53M 34.25M 31.93M 29.16M 27.36M 26.5M 25.41M 24.78M 24.05M 22.48M 21.54M
Interest Expense
8.56M 9.07M 3.71M 2.92M 2.17M 2.17M 4.43M 3.86M 2.9M 2.16M 1.04M 1.03M 893K 1.01M 1.32M 1.36M 1.51M
Selling & Marketing Expenses
3.74M 10.08M 15.29M 17.87M 17.06M 14.59M 20.96M 14.14M 9.7M 6.46M 3.38M 2.31M 1.49M 1M 905K 967K 819K
Cost & Expenses
40.32M 49.35M 49.84M 51.86M 50.61M 47.79M 39.53M 34.25M 31.93M 29.16M 27.36M 26.5M 25.41M 24.78M 24.05M 22.48M 21.54M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
79.86M 79.86M 79.86M 79.84M 72.44M 71.9M 61.94M 61.53M 61.53M 51.6M 49.38M 47.69M 47.68M 44.2M 47.23M 44.61M 37.3M
Shares Outstanding (Diluted)
79.86M 79.86M 79.86M 79.84M 72.44M 71.89M 61.94M 61.53M 61.53M 51.6M 49.38M 47.69M 47.68M 44.2M 47.23M 44.61M 37.3M
EPS (Basic)
-0.04 -0.12 -0.27 -0.45 -0.76 -0.94 -0.81 -0.69 -0.54 -0.43 -0.46 -0.45 -0.45 -0.64 -1.26 -1.37 -1.65
EPS (Diluted)
-0.04 -0.12 -0.27 -0.45 -0.76 -0.94 -0.81 -0.69 -0.54 -0.43 -0.46 -0.45 -0.45 -0.64 -1.26 -1.37 -1.65
EBITDA
8.5M 3.92M -13.32M -24.93M -44.98M -57.09M -47.54M -39M -28.92M -22.51M -21.87M -20.73M -20.23M -25.37M -32.85M -31.68M -31.42M
EBIT
5.17M -147K -16.24M -27.23M -47M -58.47M -48.41M -39.8M -29.66M -23.16M -22.51M -21.39M -20.92M -26.07M -33.58M -32.44M -32.21M
Depreciation & Amortization
3.33M 4.07M 2.92M 2.3M 2.02M 1.38M 865K 797K 740K 654K 641K 655K 694K 703K 726K 763K 795K